Search

everythinglearnresearchcommunity

for

Search:↓

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Fluconazole might be a new treatment for a type of diabetes that affects water balance in the body.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Human hair follicles may provide a noninvasive way to diagnose diseases and have potential in regenerative medicine.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

New anti-acne medications are being tested to offer alternatives to current treatments.

Stromal Vascular Fraction might help with male sexual dysfunction, but more research is needed to confirm its safety and effectiveness.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

New cell-based therapies may improve hair loss treatments in the future.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

The decision tree can predict drug absorption issues with good accuracy but needs more validation and adjustments for other factors.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

N-acetyl-cysteine shows promise in treating various diseases and may improve skin and hair conditions, but more research is needed on dosages and long-term effects.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Non-coding RNAs are crucial for skin development and health.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.